Cargando…
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
We have screened for germline TP53 mutations in Finnish BRCA1 and BRCA2 mutation-negative families. This study represents the largest survey of the entire protein-encoding portion of TP53, and indicates that mutations are only found at conserved domains in breast cancer families also meeting the cri...
Autores principales: | Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363618/ https://www.ncbi.nlm.nih.gov/pubmed/11139324 http://dx.doi.org/10.1054/bjoc.2000.1530 |
Ejemplares similares
-
Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000) -
Mutation analysis of the CHK2 gene in families with hereditary breast cancer
por: Allinen, M, et al.
Publicado: (2001) -
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
por: Vahteristo, P, et al.
Publicado: (2001) -
p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010) -
Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network
por: Pylkäs, Katri, et al.
Publicado: (2012)